|
Originally published In Press as doi:10.1074/jbc.M201886200 on March 12, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18510-18516, May 24, 2002
Cloning and Characterization of the Human Factor XI Gene
Promoter
TRANSCRIPTION FACTOR HEPATOCYTE NUCLEAR FACTOR 4 (HNF-4 )
IS REQUIRED FOR HEPATOCYTE-SPECIFIC EXPRESSION OF FACTOR XI*
Takashi
Tarumi,
Dmitri V.
Kravtsov,
Mingming
Zhao,
Scott M.
Williams , and
David
Gailani§
From the Departments of Pathology and Medicine, Vanderbilt
University, Nashville, Tennessee 37232-6307 and the
Department of Microbiology, Meharry Medical College,
Nashville, Tennessee 37208
Factor XI is the zymogen of a plasma
protease produced primarily in liver that is required for normal blood
coagulation. We cloned ~2600 base pairs of the human factor XI gene
upstream of exon one, identified transcription start sites, and
conducted a functional analysis. Luciferase reporter assays demonstrate that the 381 base pairs upstream of exon one are sufficient for maximum
promoter activity in HepG2 hepatocellular carcinoma cells. The removal
of 19 base pairs between 381 and 363 results in a nearly complete
loss of promoter activity. This region contains the sequence ACTTTG, a
motif required for binding of the transcription factor hepatocyte
nuclear factor 4 (HNF-4 ) to the promoters of several genes. Gel
mobility shift assays using HepG2 or rat hepatocyte nuclear extract
confirm HNF-4 binds between bp 375 and 360. Scrambling the
ACTTTG motif completely abolishes promoter activity in luciferase
assays. The factor XI promoter functions poorly when transfected into
HeLa carcinoma cells, and gel mobility shift experiments with HeLa
nuclear extracts demonstrate no HNF-4 binding to the ACTTTG
sequence. When a rat HNF-4 expression construct is co-transfected
into HeLa cells, factor XI promoter activity is enhanced ~10-fold. We
conclude that HNF-4 is required for hepatocyte-specific expression
of factor XI.
*
This work was supported by NHLBI, National Institutes of
Health Grant HL58837.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF486577.
§
Established Investigator of the American Heart Association. To whom
correspondence should be addressed: Division of Hematology/Oncology, Vanderbilt University, 777 Preston Research Bldg., 2220 Pierce Ave.,
Nashville, TN 37232-6307. Tel.: 615-936-1505; Fax: 615-936-3853; E-mail: dave.gailani@mcmail.vanderbilt.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Inoue and M. Negishi
Nuclear Receptor CAR Requires Early Growth Response 1 to Activate the Human Cytochrome P450 2B6 Gene
J. Biol. Chem.,
April 18, 2008;
283(16):
10425 - 10432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Muller and D. J. Danner
Tissue-specific Translation of Murine Branched-chain {alpha}-Ketoacid Dehydrogenase Kinase mRNA Is Dependent upon an Upstream Open Reading Frame in the 5'-Untranslated Region
J. Biol. Chem.,
October 22, 2004;
279(43):
44645 - 44655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Novel effect of NF-{kappa}B activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium
Am J Physiol Cell Physiol,
October 1, 2004;
287(4):
C1139 - C1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|